Proliferative pathways that are frequently overactivated, or aberrantly activated, in cancer cells are associated with the tyrosine kinase activity of membrane receptors (such as EGFR, HER2) or of cytoplasmic proteins (such as the MEK/ERK family). This evidence concerns the gene ERBB2 and cancer.